FLUMADINE
RIMANTADINE HYDROCHLORIDE
Approval overview FLUMADINE is listed in Drugs@FDA under application 019649 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient RIMANTADINE HYDROCHLORIDE Form and strength TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SUN PHARM INDS INC Submission history Latest submission status date: 2015-10-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUMADINE is listed in Drugs@FDA under application 019649 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient RIMANTADINE HYDROCHLORIDE Form and strength TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SUN PHARM INDS INC Submission history Latest submission status date: 2015-10-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.